Events2Join

High Serum Level of Plasminogen Activator Inhibitor|1 Predicts ...


High serum level of plasminogen activator inhibitor-1 predicts ...

These results suggest that the serum PAI-1 level can be a marker for the prediction of histological grade in intracerebral glioma.

High Serum Level of Plasminogen Activator Inhibitor-1 Predicts ...

Abstract. Background: No serum marker is currently available for the diagnosis and treatment of gliomas. Plasminogen activator inhibitor-1 (PAI-1) controls ...

Elevation of serum plasminogen activator inhibitor-1 predicts ...

Plasminogen activator inhibitor-1 level discriminated between patients with and without clinically diagnosed delirium with significantly high ...

Elevated levels of plasminogen activator inhibitor-1 in pulmonary ...

In conclusion, PAI-1 levels in edema fluid and plasma identify those with ALI that have a poor prognosis. The data indicate that fibrin turnover in early ALI is ...

High Plasminogen Activator Inhibitor and Tissue ... - AHA Journals

Conclusions—The plasma levels of PAI-1, tPA, and vWF are associated with subsequent development of a first AMI; for PAI-1 and tPA, this relation ...

Plasminogen activator inhibitor-1, inflammation, obesity, insulin ...

Elevated plasma PAI-1 level is a core feature of insulin-resistance syndrome (IRS), also called metabolic syndrome or syndrome X.

Association between plasminogen activator inhibitor-1 and ...

Elevated plasma PAI-1 levels have been associated with impaired fibrinolytic activity in stroke and coronary artery disease [7]. Moreover, PAI-1 ...

Elevated Plasma Levels of PAI-1 Predict Cardiovascular Events and ...

Elevated plasminogen activator inhibitor-1 (PAI-1) levels are associated with increased cardiovascular (CV) risk in the general population. It has been shown ...

Plasminogen activator inhibitor-1, inflammation, obesity, insulin ...

Elevated plasma plasminogen activator inhibitor-1 (PAI-1) level is a core feature of insulin-resistance syndrome (IRS). Atherothrombotic complications in ...

PAI1 - Overview: Plasminogen Activator Inhibitor Antigen, Plasma

Identification of heredity elevation or deficiency of plasminogen activator inhibitor type 1 Determination of risk for veno-occlusive disease associated ...

Elevated Levels of Acute-Phase Proteins and Plasminogen Activator ...

Chronic inflammation emerges as a new risk factor for the development of type 2 diabetes; PAI-1 predicts type 2 diabetes independent of insulin resistance.

Progression of Plasminogen Activator Inhibitor-1 and Fibrinogen ...

Conclusions— Progression of PAI-1 levels over time, in addition to high baseline PAI-1 levels, is associated with incident diabetes. PAI-1 ...

Blood PAI-1 and cardiovascular and metabolic risk factors among ...

The research on the role of plasminogen activator inhibitor-1 (PAI-1) in cardiovascular and metabolic diseases is insufficient.

Plasminogen Activator Inhibitor-1 - an overview | ScienceDirect Topics

PAI-1 is a regulator of blood-fibrinolytic activity and is mainly produced by white adipose tissue and visceral fat. Circulating PAI-1 levels increase in ...

Plasminogen Activator Inhibitor-1: Potential Inflammatory Marker in ...

Conclusion: This study suggests the possibility that the blood PAI-1 levels in clinically pathological late-life depression may show contrasting results to ...

Plasma Plasminogen Activator Inhibitor-1 (PAI-1) Levels in Breast ...

Cox analysis demonstrated that an elevated plasma PAI-1 level had a negative prognostic impact in terms of relapse-free (hazard ratio=2.5, p=0.021) and overall ...

Elevated levels of plasminogen activator inhibitor-1 in pulmonary ...

Both the high plasma and edema fluid PAI-1 antigen values were associated with a higher mortality rate and fewer days of unassisted ventilation in patients with ...

High levels of tissue plasminogen activator (tPA) antigen precede ...

Impaired fibrinolysis and endothelial dysfunction are evident in subjects with normal glucose tolerance who later develop diabetes. High tPA ...

Predictive value for thrombotic disease of plasminogen activator ...

Moreover, high plasma inhibitor concentrations have been observed in different disease states, but it must be stressed that plasminogen activator inhibitor-1 ...

Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti ...

These results suggest that baseline serum levels of PAI-1 may be useful as a biomarker for identifying patients with advanced cutaneous melanoma most likely to ...